EBD GmbH is part of the KNect365 of Informa PLC


This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa
 
BIO-Europe Spring EBD Group BIO BIO-Europe Spring
Share/Follow Us
Share this:
Follow this event:

BIO-Europe Spring® Press Releases

April 18, 201610th anniversary edition of BIO-Europe Spring® 2016 hosted over 2,300 life science industry executives in Stockholm, Sweden last week The who's who in the life science industry turned out for BIO-Europe Spring® 2016 in Stockholm last week. Over 2,300 executives from 1,377 companies and 49 countries engaged in 12,452 one-to-one meetings to discuss licensing opportunities, deal potential and strategic collaborations. In addition to the one-to-one partnering, the plenary "Environment in 2016: Reverse engineerin...  more ►

April 7, 2016QureTech Bio Wins the 2016 Start-up Slam: Sweden at BIO-Europe Spring ConferenceStart-up Slam is sponsored by Karolinska Institutet Innovations and Johnson & Johnson Innovation
The winner of the Start-up Slam: Sweden, a pitching competition, taking place at BIO-Europe Spring® in Stockholm for the first time on 5 April 2016, was today announced as QureTech Bio AB, a start-up developing first line drugs to combat antibiotic resistance and infectious diseases. This special session was co-sponsored by Karolinska Institutet Innovations AB and Johnson & Jo...  more ►

March 28, 2016Invitation to a Report Launch: Stockholm Business Region to release oncology summary report at BIO-Europe Spring® 2016 During BIO-Europe Spring, Stockholm Business Region is launching the report –Oncology, world-leading research and business opportunities in the Stockholm-Uppsala Region. The report is an oncology summary including the centers of excellence, innovations, current research projects, biobanks and business opportunities in the region. Where: Level 1, Hall 1, Booth #66 When: Monday, April 4...  more ►

March 16, 2016Start-up Slam: 18 early biotechs showcased in special session at BIO-Europe Spring® 2016 Pushing its reputation for taking novel approaches, Karolinska Institutet is bringing together the best and the brightest from Sweden's early academic innovator ecosystem to present their technologies and test their skills in convincing business development executives to support their projects. Some 18 companies from across the country will come together for a competitive session called Start...  more ►

February 2, 2016BIO-Europe Spring® 2016 Event in Sweden this April will bring 2,000+ life science executives to Stockholm-Uppsala region The tenth annual BIO-Europe Spring® springtime international life science partnering conference will be held in Stockholm, Sweden, April 4–6, 2016. Organized by EBD Group, the event is co-hosted by Stockholm Business Region and Stockholm Science City Foundation. The Stockholm-Uppsala region, defined as the three counties of Uppsala, Stockholm and Sörmland, is one of ...  more ►

July 30, 2015Spotlight on Stockholm/Uppsala Region Business Facts The Stockholm-Uppsala region, defined as the three counties of Uppsala, Stockholm and Sörmland, is one of the largest life science clusters in Europe. Stockholm-Uppsala region is Scandinavia's leading life science cluster and one of the world's most productive, and is one of the most competitive business environments in Europe. On average, an astounding 15–20 new...  more ►


partnering360® Blog

May 19, 2016 How drug development is like your diet If you’re like me, you read the dailies. Companies run the gamut from riding high and plump on investment infusion to rock hard abs times when they’re all muscle and no fat, and, possibly back again. With summer coming, it occurred to me that drug development cycles are very much like dieting,... more ►

May 12, 2016 From Zika virus to fast, high quality clinical trials: Puerto Rico’s Consortium for Clinical Investigation (PRCCI) Situated just 1,200 miles from the mainland US, a hotspot of clinical trial activity is being established on a small island paradise. If you haven’t heard of the Puerto Rico Consortium for Clinical Investigation (PRCCI), you should. What this organization is doing in clinical research trials for... more ►

April 29, 2016 Digital Health: Still a brave new world At this year’s BIO-Europe Spring® panel on “The Convergence of Therapeutics and Digital Health,” two panelists from big pharma joined two from Scandinavian digital health companies, agreeing that while the platform for digital health technologies is strong in Europe, much... more ►

April 19, 2016 The characteristics of a “winning” biotech startup QureTech Bio AB, a startup developing first line drugs to combat antibiotic resistance and infectious diseases, won the Start-up Slam: Sweden biotech competition at BIO-Europe Spring® 2016 in Stockholm, Sweden earlier this month. QureTech Bio AB participated in the pitching competition sponsored by... more ►

April 5, 2016 Images of BIO-Europe Spring® 2016 in Stockholm [See image gallery at www.partnering360.com] more ►



partnering360:Insight Latest headlines from partnering360:Insight

May 18, 2016 Italy’s A. Menarini IFR aims to expand into the US and Japan Giammario Piras, corporate licensing director at A. Menarini IFR, explains why and how Italy's largest drug maker plans to expand into the US and Japanese markets. more ►

May 18, 2016 BeyondSpring Pharmaceuticals outlines Plinabulin plans, wants marketing partner BeyondSpring Pharmaceuticals' chief medical officer Ramon Mohanial outlines plans for advancing the group's immuno-oncology pipeline, with ongoing Phase II and III trials of its most promising assets. more ►

May 17, 2016 Accellta CEO says israeli stem cell specialist seeks global partners Itzchak Angel, CEO of Israeli stem cell specialist Accellta, discusses the group's stem cell culturing process and future expansion plans including a planned USD 15 million capital raising exercise and ongoing search for corporate partners. more ►

May 17, 2016 AngioDesign tailoring next-generation ACE inhibitors Mario Ehlers, Chairman of drug discovery group Angio-Design (UK) explains why the design of specific domain-selective ACE inhibitors is expected to produce next-generation drugs that are safer and more effective—and generate blockbuster returns. more ►

May 17, 2016 4SC AG’s CSO outlines epigenetics strategy 4SC AG Chief Science Officer says the German cancer drug developer is conducting a Phase II trial of lead candidate ACE inhibitor resminostat in cutaneous T-cell lymphoma. more ►



Arrow Up

Follow this event:
Sign up now
For news and updates

Privacy Policy and Cookies Terms of Use

Home | Contact Us | Site Map
See more upcoming conferences ►

EBD Group's Family of Events

© 2009–2016 EBD GmbH
Privacy Policy and Cookies
Terms of Use